Observational MRI study links impaired hypoglycemia awareness to blunted cerebral blood flow responses in type 1 diabetes
Photo by Bhautik Patel / Unsplash
Key Takeaway
Recognize that impaired hypoglycemia awareness in type 1 diabetes is associated with blunted cerebral blood flow increases and altered hormone–CBF coupling.
This observational study combined hyperinsulinemic stepped clamp (euglycemia to hypoglycemia at 50 mg/dL) with pseudo-continuous arterial spin-labeling MRI to examine cerebral blood flow (CBF) and vasomotor oscillations in 26 healthy adults, 30 type 1 diabetes patients with normal hypoglycemia awareness (NAH), and 25 type 1 diabetes patients with impaired awareness of hypoglycemia (IAH). The primary outcome was CBF and sympathetic vasomotor range CBF oscillations modeled against plasma cortisol, epinephrine, norepinephrine, and glucagon.
In healthy individuals, hypoglycemia elicited robust CBF increases in thalamo-striatal and salience-interoceptive regions (mean Cohen's d = 0.93) and suppression of vasomotor oscillations (Cohen's d = 0.71). Type 1 diabetes patients retained CBF responses but failed to attenuate oscillations (dT1D>controls = 0.43). The IAH group further blunted hypoglycemia-associated CBF increases, particularly in thalamus, striatum, and insula (dNAH>IAH = 0.51).
Neuroendocrine-CBF correlations varied by group: cortisol showed positive correlation in controls (r = 0.37), negative in NAH (r = -0.16), and strongly positive in IAH (r = 0.42); epinephrine correlations were positive in controls (r = 0.26), negative in NAH (r = -0.40), and strongly positive in IAH (r = 0.46). These patterns suggest altered coupling between counterregulatory hormones and CBF in impaired awareness.
Limitations include the observational design without causal inference, absence of reported follow-up duration, and lack of adverse event data. The study does not report sample sizes for specific brain regions or subgroup analyses beyond the main comparisons. Findings indicate that impaired awareness may reflect neurovascular dysregulation, but clinical translation requires further validation and safety assessment.
More on Type 1 Diabetes
Meta-analysis finds slight IQ difference in children with type 1 diabetes versus peers
Children with diabetes show slightly lower IQ scores than peers
This meta-analysis of 16 studies examined cognitive outcomes in children and adolescents with type 1 diabetes. It found a slight reduction i…
New research shows kids with type 1 diabetes may have slightly lower IQ scores but large groups show no reading or language gaps
Barriers and promoters to CGM and AID use in youth with T1D and public insurance
New plan helps families with public insurance get life-saving diabetes tech
This prospective, mixed-methods study examined barriers and promoters to continuous glucose monitoring (CGM) and artificial insulin delivery…
A new study reveals why families with public insurance struggle to get diabetes tech and offers a custom plan to fix it.
FDA Approves Tzield (teplizumab) to Delay Onset of Stage 3 Type 1 Diabetes
FDA approves Tzield to delay type 1 diabetes in high-risk patients
The FDA approved Tzield (teplizumab) to delay the onset of Stage 3 type 1 diabetes in patients aged 1 year and older with Stage 2 disease. T…
The FDA approved Tzield (teplizumab) to delay the onset of stage 3 type 1 diabetes in people aged 1 and older with stage 2 disease. This is …
Beta-cell stress responses contribute to early Type 1 diabetes development and disease progression.
Type 1 Diabetes May Start Inside the Cell, Not Just the Immune System
This perspective and review of human tissue, single cell transcriptomics, and longitudinal cohort studies indicates that beta-cell stress re…
This study shifts the focus of Type 1 diabetes from a pure immune problem to a two-part story where stressed cells play a key role.
View Original Abstract ↓
BACKGROUNDRecurrent hypoglycemia in type 1 diabetes (T1D) may culminate in impaired awareness of hypoglycemia (IAH). While neuroimaging studies identified affected brain regions, more complex perspectives integrating vascular dynamics with endocrine profile are needed.METHODSHere, 26 healthy adults, 30 T1D patients with normal hypoglycemia awareness (NAH), and 25 T1D patients with IAH underwent a hyperinsulinemic stepped clamp (euglycemia → hypoglycemia 50 mg/dL) combined with pseudo-continuous arterial spin-labeling MRI. Cerebral blood flow (CBF) and sympathetic vasomotor range (0.02-0.05 Hz) CBF oscillations were modeled against serially sampled plasma cortisol, epinephrine, norepinephrine, and glucagon.RESULTSIn healthy individuals treated as controls, hypoglycemia evoked robust thalamo-striatal and salience-interoceptive CBF increases (mean Cohen's d across significant clusters = 0.93) and suppression of vasomotor oscillations (d = 0.71). T1D retained CBF response but failed to attenuate oscillations (dT1D>controls = 0.43). IAH further blunted hypoglycemia-associated CBF increase, especially in thalamus, striatum, and insula (dNAH>IAH = 0.51). Hormone-CBF coupling differed quantitatively: cortisol/epinephrine-CBF correlations were positive in controls (r = 0.37/0.26), negative in NAH (-0.16/-0.40), and strongly positive in IAH (0.42/0.46).CONCLUSIONThus, our findings indicate that T1D disrupts dynamic, sympathetic modulation of CBF, whereas IAH additionally impairs perfusion reserve and shows maladaptive catecholamine-dependent CBF regulation, suggesting a qualitatively distinct neurovascular phenotype.TRIAL REGISTRATIONClinicalTrials.gov: NCT02747680 and NCT02866435.FUNDINGNIH (P41-EB-015894, P30-NS-076408, R01-DK-099137, R56-DK-099137, and DP1 AG093028); National Center for Advancing Translational Sciences of the NIH (KL2-TR-000113 and UL1-TR-000114); DP1 AG093028; Charles University, Czech Republic (Cooperatio Program, research area NEUR), Brain Dynamics (grant number CZ.02.01.01/00/22_008/0004643); General University Hospital in Prague (MH CZ-DRO-VFN64165).
Tirzepatide MTD Demonstrates Cost-Effectiveness Versus Semaglutide MTD in Obesity Simulation Modeling Study
Tirzepatide Saves Money and Health Over Semaglutide
Related in Diabetes & Endocrinology
Review of NHANES data links metformin use to lower mortality and inflammatory markers in type 2 diabetes
Metformin use linked to lower death risk and better inflammation markers in U.S. adults with diabetes
This review of NHANES 2013-2018 data (2,116 adults) found that metformin use was associated with lower all-cause and cardiovascular mortalit…
New analysis of U.S. adults with diabetes suggests metformin use connects to lower death risk and improved inflammation markers, though more…
A 1-month nudge-based dietary intervention increased daily step counts by 1105 steps at 3 months in adults with type 2 diabetes.
Small diet changes might boost steps for a short time in diabetes care
This cluster-randomised controlled trial enrolled 204 adults aged 18-59 years with type 2 diabetes across 12 primary healthcare centres in B…
A simple diet plan helped people with diabetes walk more for three months but the extra steps did not stick in the long run
Mobile app plus group sessions showed feasibility in Malaysian women with gestational diabetes
A new app plus support for diabetes care in Malaysia showed no benefit yet.
This feasibility randomized controlled trial enrolled 60 women with gestational diabetes mellitus in Malaysia. The intervention included mob…
A trial in Malaysia found that a mobile app and group sessions did not improve health outcomes for women with gestational diabetes compared …
Oral Sodium Butyrate Reduces Weight in Overweight Adults Without Diabetes
Oral sodium butyrate helps overweight adults without diabetes lose weight
This 12-week proof-of-concept RCT in 46 overweight adults (23 with type 2 diabetes) found that oral sodium butyrate 1875 mg/day led to great…
A new trial shows oral sodium butyrate helps adults without diabetes lose more weight than a placebo over three months.
From Other Specialties
Systematic review and meta-analysis shows cefotiam reduces postoperative infection in clean surgery
Cefotiam cuts post-surgery infection risk by half compared to no antibiotics
This systematic review and meta-analysis evaluated cefotiam prophylaxis versus no antibiotic prophylaxis or other beta-lactam agents in adul…
A large review found cefotiam lowers infection risk after clean surgery. It works as well as other common antibiotics without causing more s…
Therapeutic Touch Reduces Crying and Improves Sleep in Infants With Colic
Therapeutic touch reduces crying in babies with colic
This randomized controlled trial in 96 infants with colic found that therapeutic touch based on Watson's Human Care Theory significantly red…
A new trial shows gentle therapeutic touch helps babies cry less and sleep better when they have infantile colic.
Mycophenolate mofetil non-inferior to prednisone for first-episode nephrotic syndrome in children
Mycophenolate Mofetil Offers Alternative to Steroids for Nephrotic Syndrome
This phase 3 non-inferiority trial randomized 272 children aged 1-10 years with first-episode steroid-sensitive nephrotic syndrome to mycoph…
A new trial shows mycophenolate mofetil works as well as prednisone for children with nephrotic syndrome, with fewer steroid side effects.
AquOTic water competency intervention improves outcomes in children with autism
Water therapy improves skills for children with autism spectrum disorder
This pre-post cohort study of 37 children with autism ages 5 to 9 found that a 10-week occupational therapy-based water competency intervent…
A water-based occupational therapy program significantly improved performance and satisfaction scores in children with autism spectrum disor…